FDA Panel to Weigh Moderna Vaccine for Those Aged 6 to 17
TUESDAY, June 14, 2022 (HealthDay News) — The U.S. Food and Drug Administration’s vaccine advisory panel will decide on Tuesday whether to recommend the agency approve the emergency use of Moderna’s COVID-19 vaccine in children aged 6 to 17. The panel will analyze Moderna’s two-dose vaccine for children aged 6Continue Reading










